Fermenta Announces Granting of CEP by EDQM for VITADEETM 100 SD, Enabling Accelerated Global Growth

▴ Fermenta Biotech Limited
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3.

Thane, India – 29th July 2025 – Fermenta Biotech Limited (“Fermenta”), a pioneer in pharmaceutical and nutritional ingredients; one of the world’s leading manufacturers of Vitamin D3, is pleased to announce that it has received the Certificate of Suitability (CEP) by the European Directorate for the Quality of Medicines & Healthcare (EDQM) for its SprayDried variant, VITADEETM 100 SD - CHOLECALCIFEROL CONCENTRATE (POWDER FORM) 100, 000 IU/g being manufactured at its Kullu, Himanchal Pradesh facility.

Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3. The approval underscores Fermenta’s adherence to the stringent European Pharmacopoeial Standards for manufacturing and product quality.

Commenting on the achievement, Mr Prashant Nagre, Managing Director of Fermenta, shared:

“As we enter our 75th year, receiving the CEP for VITADEE™ 100 SD marks a significant milestone for Fermenta. It reinforces our commitment to the benchmarks of regulatory compliance by growing our product portfolio whilst strengthening our position as an established global partner in the field of Vitamin D3. This accreditation also enables us to move further up the value chain and stands as yet another testament to our focus on excellence, innovation, and trust.” 

This recognition further enhances Fermenta’s international footprint and our capability to deliver products that meet the highest global quality and regulatory standards. It represents another step forward in our mission to expand our global presence and create meaningful impact across the health and nutrition industry.

About Fermenta Biotech Limited

Founded in 1951, Fermenta Biotech Limited (Fermenta) possesses a growing portfolio of nutrition including Customized Premixes, Fortified Rice Kernel (FRK) and other nutritional ingredients. Apart from its nutrition portfolio, Fermenta is one of the world’s leading manufacturers of Vitamin D3. It caters to over 400 customers across 60 countries with a worldwide distribution network for a variety of applications such as pharmaceuticals, dietary and nutritional supplements, food, animal nutrition and rodenticides. Fermenta's manufacturing facilities in Kullu, Dahej and Tirupati are certified by global accreditations, and its world class R&D centre is located at Thane. Fermenta also possesses expertise in green chemistry such as enzymes for antibiotic synthesis, other niche APIs and environmental solutions.  

For more information about Fermenta and its business, please visit our website www.fermentabiotech.com  

Safe Harbor

Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, the progress and results of research and development, potential project characteristics, project potential and target dates for project related issues are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements. Fermenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Modern Interventions in Maxillofacial Trauma: Soft Tissue Repair and Internal Fixation FrameworksAugust 20, 2026
Building Disaster Recovery Protocols for Hospital IT: Ensuring 99.9% Uptime During OutagesAugust 20, 2026
Importance of Nutrition: Why What You Eat Shapes Your Health, Energy, and FutureAugust 20, 2026
Stress Management: Causes, Symptoms, Signs and Effective Relief StrategiesAugust 20, 2026
Vulnerable families in Chennai receive free eye check-up in collaborative camp from SOS Children’s Villages India and Dr Agarwals Eye HospitalAugust 19, 2026
Kauvery Hospital Builds an Integrated Epilepsy-Care Network Across Its Chennai HospitalsAugust 19, 2026
NIIMS Observes World Breastfeeding Week 2026 with Community Outreach, Awareness Sessions and Practical Nutrition ActivitiesAugust 19, 2026
Apollo Hospitals launches ‘Always Open, Always Here’, a global first in healthcare from IndiaAugust 19, 2026
110 West Bengal MLAs Participated in ICAI Workshop on Strengthening Public Financial Management August 19, 2026
Man Matters Becomes the First Men’s Health Platform in India to Bring At-Home Blood Testing for Hair HealthAugust 19, 2026
Child Nutrition Guide for Indian Parents: Age-Wise Dietary Needs and Healthy Eating HabitsAugust 19, 2026
Medical Technology Explained: What It Is, How It Works, and Why It Matters for Indian HealthcareAugust 19, 2026
Even Hospital Secures NABH 6th Edition Accreditation Within First Year, Validating Its Outcome-Driven Care ModelAugust 18, 2026
OpenAI launches film featuring Tisca Chopra as it introduces ChatGPT for Teens with stronger safety protectionsAugust 18, 2026
PRHUB strengthens leadership to fuel transformation & next phase of growthAugust 18, 2026
MGM Healthcare Malar Removes Massive 890-Gram Brain Tumour, One of the Largest Ever ReportedAugust 18, 2026
Care Health Insurance Issues Public Health Advisory on Mosquito-Borne DiseasesAugust 18, 2026
Mental Health Awareness in India: Understanding the Signs, Bridging the Gap, and Finding HopeAugust 18, 2026
Stress Management in India: Understanding Causes, Symptoms, and Proven Techniques That WorkAugust 18, 2026
Traya Health's Social Experiment Opens Up the Evolutionary Science Behind Why People Reject Partners with Hair LossAugust 17, 2026